Effectiveness of Acupuncture in Post-Mastectomy Patients With Tissue Expanders
NCT ID: NCT02639611
Last Updated: 2016-08-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2013-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acupuncture and Breast Cancer Rehabilitation
NCT02691208
Acupuncture or Medication in Reducing Pain in Postmenopausal Women With Breast Cancer and Joint Pain
NCT00892268
Preoperative Relaxation Training and Acupuncture to Minimize Perioperative Symptoms in Breast Cancer Patients
NCT02276404
The Efficacy of Acupuncture as a Complementary Treatment for Pain and Anxiety After Breast Cancer Surgery
NCT04608175
A Pilot Trial to Assess the Impact of Acupuncture on Post-mastectomy Pain, Nausea, Anxiety and Ability to Cope
NCT02122796
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Immediate Post Operative Acupuncture Treatment
Immediate Post Operative Acupuncture Treatment
acupuncture treatment immediately after surgery (twice a week for 6 weeks)
Acupuncture Treatment After 6 Weeks of Recovery
No Acupuncture Treatment
no acupuncture treatment for 6 weeks, but offered acupuncture at the end of the 6 week study period.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Immediate Post Operative Acupuncture Treatment
acupuncture treatment immediately after surgery (twice a week for 6 weeks)
No Acupuncture Treatment
no acupuncture treatment for 6 weeks, but offered acupuncture at the end of the 6 week study period.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Women who are newly diagnosed with breast cancer
* Women who are enrolled in the Breast Cancer Database (BCD)
* Women who are having breast cancer surgery involving a mastectomy procedure with insertion of a tissue expander for reconstructive purposes
Exclusion Criteria
* Women who had neoadjuvant chemotherapy and/or radiation therapy
* Women who are currently on anticoagulant therapy
* Women who are having breast reconstruction with Alloderm
* Women who have chronic pre-operative pain
* Women who have had a history of previous implants or prior augmentations
* Women who are currently on anticoagulant therapy
* Women who are having breast reconstruction with Alloderm
* Women who have chronic pre-operative pain
* Women who have had a history of previous implants or prior augmentations
18 Years
79 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NYU Langone Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Freya Schnabel, MD
Role: PRINCIPAL_INVESTIGATOR
New York University Medical School
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New York University School of Medicine
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12-03266
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.